IRIS
PAPPONE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.161
NA - Nord America 4.866
EU - Europa 2.989
SA - Sud America 2.683
AF - Africa 171
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 5
Totale 17.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.657
SG - Singapore 3.185
BR - Brasile 2.253
CN - Cina 1.652
HK - Hong Kong 1.035
SE - Svezia 957
VN - Vietnam 742
RU - Federazione Russa 419
IT - Italia 318
RO - Romania 269
DE - Germania 252
IE - Irlanda 223
FI - Finlandia 203
AR - Argentina 174
ID - Indonesia 92
GB - Regno Unito 90
MX - Messico 90
IN - India 87
BD - Bangladesh 79
EC - Ecuador 76
CA - Canada 67
ZA - Sudafrica 62
AT - Austria 55
CO - Colombia 47
IQ - Iraq 45
PL - Polonia 38
TR - Turchia 33
PY - Paraguay 32
JP - Giappone 31
FR - Francia 28
NL - Olanda 28
VE - Venezuela 25
UA - Ucraina 24
MA - Marocco 23
PK - Pakistan 23
UY - Uruguay 23
UZ - Uzbekistan 23
CL - Cile 22
ES - Italia 18
LT - Lituania 18
PE - Perù 18
SA - Arabia Saudita 18
DZ - Algeria 17
EG - Egitto 14
AZ - Azerbaigian 13
KZ - Kazakistan 13
TN - Tunisia 13
BO - Bolivia 12
EU - Europa 12
KE - Kenya 12
OM - Oman 11
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 10
NP - Nepal 10
HN - Honduras 8
SN - Senegal 8
BE - Belgio 7
IR - Iran 7
MD - Moldavia 7
CR - Costa Rica 6
JM - Giamaica 6
LB - Libano 6
AL - Albania 5
AM - Armenia 5
ET - Etiopia 4
JO - Giordania 4
KW - Kuwait 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KR - Corea 3
LV - Lettonia 3
LY - Libia 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CD - Congo 2
CH - Svizzera 2
DK - Danimarca 2
DM - Dominica 2
GA - Gabon 2
GE - Georgia 2
IM - Isola di Man 2
KH - Cambogia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
Totale 17.866
Salva come PNG Salva come JPEG
Città #
Dallas 2.225
Singapore 1.170
Hong Kong 1.032
Hefei 460
Shanghai 454
Lawrence 430
Princeton 429
Ashburn 332
Ho Chi Minh City 315
Dublin 223
São Paulo 172
Helsinki 170
Hanoi 142
Beijing 133
Milan 99
New York 89
Rio de Janeiro 71
Moscow 70
Los Angeles 55
Nuremberg 55
Boardman 52
Curitiba 44
Brasília 43
Munich 41
Belo Horizonte 39
Warsaw 35
Porto Alegre 34
Da Nang 32
Santa Clara 31
Haiphong 30
Johannesburg 30
Tianjin 29
Denver 27
Salvador 27
Brooklyn 26
Campinas 26
Guayaquil 25
Tokyo 25
Pune 24
Vienna 24
Biên Hòa 22
London 22
Rome 22
Seattle 22
Toronto 22
Quito 21
Stockholm 21
Tashkent 21
Atlanta 20
Baghdad 20
Guangzhou 20
Phoenix 20
Boston 19
Caxias do Sul 19
Frankfurt am Main 19
Goiânia 19
Santo André 19
Washington 19
Guarulhos 18
Montevideo 18
Osasco 18
Poplar 18
Ribeirão Preto 18
Chicago 16
Council Bluffs 16
Fortaleza 16
Hải Dương 16
Lappeenranta 16
Recife 16
Turku 16
Buenos Aires 15
Chennai 15
San Francisco 15
Asunción 14
Formosa 14
Manchester 14
Amsterdam 13
Aracaju 13
Canoas 13
Cesano Boscone 13
Jakarta 13
Montreal 13
Orem 13
Sorocaba 13
Thái Bình 13
Thái Nguyên 13
Ankara 12
Baku 12
Bauru 12
Cape Town 12
Dhaka 12
Joinville 12
Nairobi 12
Querétaro 12
São Bernardo do Campo 12
Campo Grande 11
Hangzhou 11
Houston 11
Lima 11
São Gonçalo 11
Totale 9.719
Salva come PNG Salva come JPEG
Nome #
1. Cardiac Resynchronization Therapy with Multisite Left Ventricular Pacing Improves Acute Hemodynamic Response in Patients 1.369
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 157
A 20-joule electrical cardioversion applied directly to the heart elevates troponin I by at least 1.5 ng.mL(-1) 113
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society 100
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 97
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 97
A controlled randomized trial of biatrial ablation for curing long-lasting permanent atrial fibrillation (the Decomplex Trial) 96
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 94
65. Cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure early multicenter experience 91
Ablation catheter with flexible tip and methods of making the same 87
A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome 84
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 80
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach 80
[A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways] 79
[Atrioventricular conduction before and after the radiofrequency catheter ablation of a nodal reentry tachycardia circuit] 79
Brugada syndrome genetics is associated with phenotype severity 78
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 77
[The physical and chemical principles of radiofrequency catheter ablation in arrhythmias] 77
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 76
[Ablation of paroxysmal tachycardia in Wolff-Parkinson-White syndrome] 76
“Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases” 74
[Prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia] 74
“Cardiac Resynchronization Therapy” 72
A randomized study of prophyl actic catheter ablation in high-risk children with asymptomatic Wolff-Parkinson-White syndrome 71
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study 70
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 70
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 69
HIF-1α Directly Controls WNT7A Expression During Myogenesis 69
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 68
“Stroke Prevention: Left Atrial Appendage Occlusion” 67
Brugada Syndrome: Warning of a Systemic Condition? 66
[Radiofrequency catheter ablation of atrial tachycardia: technique, results and follow-up] 66
“How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance” 64
“Circumferential Pulmonary Vein Ablation With MediGuide® System” 64
“How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques 64
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 63
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 60
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 60
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 59
“Management of Advanced Atrial Fibrillation” 58
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 58
Calcium in Brugada syndrome: Questions for future research 58
Antitachycardia devices for the treatment of recurrent ventricular tachycardia: long term results 57
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 57
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 56
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 55
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002” 55
The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction 55
The APAF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial [Die APAF-studie: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial] 54
Stereotaxis “Atrial Fibrillation Ablation” 53
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 52
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 52
Management of severe cardiac arrhythmic events in elite athletes 51
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 50
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 50
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation 50
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 50
Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram 49
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 49
Brugada Syndrome: Oligogenic or Mendelian Disease? 49
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry 49
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 49
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 47
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 47
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 47
Atrial fibrillation in elite athletes 46
Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury 46
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 46
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis 46
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate 45
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 45
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation 45
Primary atrial tachycardia: techniques for intracardiac mapping and radiofrequency ablation 45
Fibroma of the left ventricle in a patient with Sotos syndrome 45
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 45
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis 44
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: Mid-term safety and efficacy results from a multicenter study 44
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 44
Quantitative assessment of left ventricular contractile synchrony during biventricular pacing using color kinesis echocardiography 44
False-positive noninvasive test results in hypertensives with no coronary artery disease from the stress testing hypertension (STH) trial 44
Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study 44
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 44
Circumferential pulmonary-vein ablation for chronic atrial fibrillation 43
Atrial Fibrillation Progression in Patients With and Without Lone Atrial Fibrillation: A Five-Year Prospective Follow-Up Study 43
High-Risk Arrhythmic presenting profile did not predict the need for defibrillation backup in cardiac resynchronization therapy patients 43
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society 43
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) 43
Control for a Remote Navigation System 42
Atrial fibrillation ablation in patients with mechanical mitral valves: safety, frasibility and outcome 42
Atrial fibrillation ablation: a realistic alternative to pharmacologic therapy 42
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 42
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 42
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 42
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 42
Method of treating cardiac arrhythmias 41
System and methods for locating and ablating arrhythomogenic tissues 41
Prevalence, mechanisms and clinical significance of atrial tachycardia following circumferential pulmonary vein ablation 41
Fast-track Determination of Best CRT Lead Position by Stereotaxis and Left Ventricular Pressure-Volume and Dyssynchrony Analysis 41
Complicanze delle procedure di ablazione transcatetere: diagnosi e trattamento 41
Compound heterozygous SCN5A gene mutations in asymptomatic Brugada syndrome child 41
Totale 7.231
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 1 4 30 2 0 0 0
2021/2022176 0 0 0 92 8 9 19 3 23 2 13 7
2022/20232.266 1.075 447 106 18 6 180 224 77 83 32 14 4
2023/2024563 39 23 59 78 39 69 14 57 0 28 38 119
2024/20255.686 838 79 26 77 122 388 824 456 1.154 903 375 444
2025/20269.305 1.070 1.665 2.530 2.918 1.039 83 0 0 0 0 0 0
Totale 18.425